Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.500 Therapeutic phenotype RGD Dietary intake of medium- and long-chain triacylglycerols ameliorates insulin resistance in rats fed a high-fat diet. 21872431 2012
Entrez Id: 5562
Gene Symbol: PRKAA1
PRKAA1
0.500 Biomarker phenotype RGD These findings indicated that the decrease in lipin1 expression and AMPKα activation may contribute to hepatic insulin resistance in diet-induced obese rats. 22231922 2012
Entrez Id: 6720
Gene Symbol: SREBF1
SREBF1
0.500 Biomarker phenotype CTD_human Impact of dietary fat quantity and quality on skeletal muscle fatty acid metabolism in subjects with the metabolic syndrome. 22658938 2012
Entrez Id: 32
Gene Symbol: ACACB
ACACB
0.500 Biomarker phenotype CTD_human Impact of dietary fat quantity and quality on skeletal muscle fatty acid metabolism in subjects with the metabolic syndrome. 22658938 2012
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.500 Therapeutic phenotype RGD Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism. 23089228 2012
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.500 Therapeutic phenotype CTD_human Dual acting and pan-PPAR activators as potential anti-diabetic therapies. 21484566 2011
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Therapeutic phenotype CTD_human These studies indicate that SIRT1 serves as a negative regulator of UPR signaling in T2DM and that SIRT1 attenuates hepatic steatosis, ameliorates insulin resistance, and restores glucose homeostasis, largely through the inhibition of mTORC1 and ER stress. 21321189 2011
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.500 Biomarker phenotype RGD Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat. 23154293 2011
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Biomarker phenotype CTD_human These studies indicate that SIRT1 serves as a negative regulator of UPR signaling in T2DM and that SIRT1 attenuates hepatic steatosis, ameliorates insulin resistance, and restores glucose homeostasis, largely through the inhibition of mTORC1 and ER stress. 21321189 2011
Entrez Id: 5562
Gene Symbol: PRKAA1
PRKAA1
0.500 Biomarker phenotype CTD_human AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. 19934007 2010
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.500 Biomarker phenotype CTD_human Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. 20567778 2010
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Therapeutic phenotype CTD_human In vivo, insulin resistance and metabolic syndrome were associated with low PBMC SIRT1 gene and protein expression. 20068143 2010
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Biomarker phenotype CTD_human In vivo, insulin resistance and metabolic syndrome were associated with low PBMC SIRT1 gene and protein expression. 20068143 2010
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Therapeutic phenotype RGD In conclusion, these results define a novel role for SIRT1 as an important regulator of macrophage inflammatory responses in the context of insulin resistance and raise the possibility that targeting of SIRT1 might be a useful strategy for treating the inflammatory component of metabolic diseases. 19996381 2010
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.500 Biomarker phenotype CTD_human The aim of this study was to examine the extent to which quercetin and trans-RSV prevented inflammation or insulin resistance in primary cultures of human adipocytes treated with tumor necrosis factor-α (TNF-α)-an inflammatory cytokine elevated in the plasma and adipose tissue of obese, diabetic individuals. 20943792 2010
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Biomarker phenotype CTD_human These data highlight the potential utility of eNOS gene therapy in the treatment of hypertension and insulin resistance. 19008412 2009
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Therapeutic phenotype CTD_human These data highlight the potential utility of eNOS gene therapy in the treatment of hypertension and insulin resistance. 19008412 2009
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.500 Biomarker phenotype RGD The passive coping Roman Low Avoidance rat, a non-obese rat model for insulin resistance. 19296906 2009
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.500 Therapeutic phenotype CTD_human Adiponectin is an adipocyte-derived protein that acts to reduce insulin resistance in the liver and muscle and also inhibits atherosclerosis. 18931039 2009
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.500 Biomarker phenotype CTD_human INT131: a selective modulator of PPAR gamma. 19452630 2009
Entrez Id: 154
Gene Symbol: ADRB2
ADRB2
0.500 Biomarker phenotype CTD_human The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker. 19034036 2008
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Biomarker phenotype RGD And compared with 4-week IR control rats, the levels of CO, TAOC, SOD and eNOS were increased, while the levels of SABP and iNOS activity were lower in the hemin treated IR group. 18298918 2008
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.500 Biomarker phenotype RGD Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. 18385463 2008
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.500 Biomarker phenotype CTD_human The insulin resistance associated with glucotoxicity in our model reflects in part decreased availability of PtdIns(3,4,5)P3, which correlates with increased PTEN protein expression. 18303120 2008
Entrez Id: 6720
Gene Symbol: SREBF1
SREBF1
0.500 Biomarker phenotype RGD Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. 17241878 2007